首页>
外国专利>
Cancer therapeutic agent using IL-18 and molecular target antibody in combination
Cancer therapeutic agent using IL-18 and molecular target antibody in combination
展开▼
机译:结合使用IL-18和分子靶标抗体的癌症治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.
展开▼